Stock THQM TCHAIKAPHARMA HIGH QUALITY MEDICINES AD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tchaikapharma High Quality Medicines AD

Equities

THQM

BG1100008074

Pharmaceuticals

End-of-day quote Bulgaria S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
17.3 BGN -0.57% Intraday chart for Tchaikapharma High Quality Medicines AD -0.57% +1.76%
Apr. 24 Tchaikapharma High Quality Medicines AD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 22 Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 649.8 896 1,141 1,259 1,360 1,510
Enterprise Value (EV) 1 659.9 908 1,153 1,271 1,372 1,521
P/E ratio 54.8 x 273 x 3,381 x 746 x 469 x 444 x
Yield - - - - - -
Capitalization / Revenue 17.1 x 25.5 x 28.5 x 29.7 x 31.7 x 31.1 x
EV / Revenue 17.3 x 25.9 x 28.8 x 30 x 31.9 x 31.3 x
EV / EBITDA 41.9 x 136 x 251 x 227 x 211 x 246 x
EV / FCF -180 x 1,315 x 91.3 x 1,499 x -1,770 x -631 x
FCF Yield -0.55% 0.08% 1.1% 0.07% -0.06% -0.16%
Price to Book 6.91 x 9.25 x 11.8 x 12.7 x 13.4 x 14.4 x
Nbr of stocks (in thousands) 88,800 88,800 88,800 88,800 88,800 88,800
Reference price 2 7.318 10.09 12.85 14.18 15.32 17.00
Announcement Date 3/28/19 1/30/20 3/1/21 2/28/22 2/28/23 4/10/24
1BGN in Million2BGN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 38.06 35.07 40.03 42.43 42.96 48.51
EBITDA 1 15.74 6.694 4.588 5.591 6.501 6.182
EBIT 1 12.43 3.378 0.363 1.796 3.17 4.007
Operating Margin 32.65% 9.63% 0.91% 4.23% 7.38% 8.26%
Earnings before Tax (EBT) 1 12.42 3.059 0.554 1.899 3.251 3.868
Net income 1 11.2 2.845 0.344 1.667 2.901 3.398
Net margin 29.43% 8.11% 0.86% 3.93% 6.75% 7%
EPS 2 0.1334 0.0370 0.003800 0.0190 0.0327 0.0383
Free Cash Flow 1 -3.659 0.6905 12.62 0.848 -0.7751 -2.412
FCF margin -9.61% 1.97% 31.53% 2% -1.8% -4.97%
FCF Conversion (EBITDA) - 10.32% 275.14% 15.17% - -
FCF Conversion (Net income) - 24.27% 3,669.55% 50.87% - -
Dividend per Share - - - - - -
Announcement Date 3/28/19 1/30/20 3/1/21 2/28/22 2/28/23 4/10/24
1BGN in Million2BGN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 10.1 12 12 11.8 11.7 11.1
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.6432 x 1.789 x 2.613 x 2.116 x 1.794 x 1.796 x
Free Cash Flow 1 -3.66 0.69 12.6 0.85 -0.78 -2.41
ROE (net income / shareholders' equity) 12.7% 2.98% 0.36% 1.7% 2.89% 3.29%
ROA (Net income/ Total Assets) 7.47% 1.85% 0.19% 0.96% 1.67% 2.07%
Assets 1 150 153.4 177.9 173.6 173.6 164.4
Book Value Per Share 2 1.060 1.090 1.090 1.110 1.150 1.180
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 1.4 0.99 2.82 1.57 1.58 1.91
Capex / Sales 3.68% 2.82% 7.04% 3.71% 3.68% 3.94%
Announcement Date 3/28/19 1/30/20 3/1/21 2/28/22 2/28/23 4/10/24
1BGN in Million2BGN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
TCHAIKAPHARMA HIGH QUALITY MEDICINES AD Stock Tchaikapharma High Quality Medicines AD
+1.76% 839M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. THQM Stock
  4. Financials Tchaikapharma High Quality Medicines AD